RVL Pharmaceuticals plc Fair Value of Long-Term Debt
RVL Pharmaceuticals plc had Fair Value of Long-Term Debt of $53.04 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2023-08-14
- 2023-03-31: Long-term Debt, Fair Value $53.04M.
- 2022-12-31: Long-term Debt, Fair Value $55.50M.
- 2022-09-30: Long-term Debt, Fair Value $55.90M.
- 2022-06-30: Long-term Debt, Fair Value $42.90M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2023-03-31 | $53.04M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $55.50M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $55.90M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $42.90M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $45.10M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $43.80M 10-K · filed 2023-03-20 |
| 2020-12-31 | $219.53M 10-K · filed 2022-03-30 |